Semaglutide requires weekly injections and often causes gastrointestinal side effects, while AOD-9604 is generally well-tolerated with minimal digestive impact
That said, no formal head-to-head comparison of AOD 9604 versus GLP-1 agents for muscle preservation has been conducted
GLP-1 drugs work through appetite suppression
Most patients see measurable changes in their body composition around three to four weeks into their plan, with a steady fat loss of 0.51.5 lbs per week from weeks five to eight, especially when pairing AOD 9604 with nutrition and training
They may have underreported minor discomforts that did not meet thresholds for adverse event classification
Our AI-powered assistance answers your specific questions about timing, combinations, side effects, and optimization strategies tailored to your situation